论文部分内容阅读
（目的）探讨转移性肝癌的外放射、肝动脉化疗栓塞的综合治疗价值。（方法）回顾性分析转移性肝癌的肝动脉化疗栓塞、外放射综合治疗（28例）及单纯外放射治疗（25例）的治疗效果。〔结果〕综合治疗组的有效率为53．6％，1年、2年、3年生存率分别为60．7％、32．2％、14．3％，单纯放疗组的有效率为32％，1年、2年、3年生存率分别为44．0％、28．0％、12．0％。综合治疗组、单纯放疗组的平均生存期分别为14．6个月、11．8个月。其中III期患者的平均生存期综合治疗组（13．4个月）明显优于单纯放疗组（7．1个月，P＜0．05）。（结论）综合治疗未能提高I、II期转移性肝癌的治疗效果，但能明显延长III期患者的生存期。
(Objective) To investigate the comprehensive treatment value of external radiotherapy and hepatic arterial chemoembolization in metastatic liver cancer. (Methods) The therapeutic effects of hepatic arterial chemoembolization, external radiation therapy (28 cases) and external radiotherapy (25 cases) of metastatic liver cancer were retrospectively analyzed. 〔Results〕 The effective rate in the comprehensive treatment group was 53.6%. The one-, two-, and three-year survival rates were 60.7%, 32.2%, and 14.3%, respectively. The radiotherapy group had an effective rate of 32. The %, 1-year, 2-year, and 3-year survival rates were 44.0%, 28.0%, and 12.0%, respectively. The average survival time of the comprehensive treatment group and the radiotherapy alone group was 14.6 months and 11.8 months, respectively. The average survival time of stage III patients in the comprehensive treatment group (13.4 months) was significantly better than that of the single radiotherapy group (7.1 months, P<0.05). (Conclusion) Comprehensive treatment failed to improve the therapeutic effect of stage I and II metastatic liver cancer, but it can significantly prolong the survival period of stage III patients.